Andrographolide interferes with binding of nuclear factor-κB to DNA in HL-60-derived neutrophilic cells

British Journal of Pharmacology

Volumn 144, Issue 5, 2005, Pages 680-686

  Hidalgo, Marí A ^a   Romero, Alex ^a   Figueroa, Jaime ^a   Cortés, Patricia ^b   Concha, Ilona I ^a   Hancke, Juan L ^a   Burgos, Rafael A ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Andrographolide; COX 2; fMLP; HL 60 cells; Neutrophils; NF B; PAF

Indexed keywords

ANDROGRAPHOLIDE; CYCLOOXYGENASE 2; DITERPENE; DNA; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HERBACEOUS AGENT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; THROMBOCYTE ACTIVATING FACTOR;

ANDROGRAPHIS PANICULATA; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CELL VIABILITY; DNA BINDING; DRUG TARGETING; ELECTROPHORETIC MOBILITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; HERBAL MEDICINE; HUMAN; HUMAN CELL; NEUTROPHIL; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; DITERPENES; DNA; HL-60 CELLS; HUMANS; LUCIFERASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLATELET ACTIVATING FACTOR;

EID: 15944409586     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706105     Document Type: Article

References (48)

1. ALI, S. & MANN, D.A. (2004). Signal transduction via the NF-kappaB pathway: a targeted treatment modality for infection, inflammation and repair. Cell Biochem. Funct., 22, 67-79.
2. BAEUERLE, P.A. & BALTIMORE, D. (1996). NF-kappa B: ten years after. Cell, 87, 13-20.
3. BAEUERLE, P.A. & HENKEL, T. (1994). Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol., 12, 141-179.
4. BALDWIN JR, A.S. (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol., 14, 649-683.
5. BARNES, P.J. & KARIN, M. (1997). Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med., 336, 1066-1071.
6. BAZAN, H.E., TAO, Y., DECOSTER, M.A. & BAZAN, N.G. (1997). Platelet-activating factor induces cyclooxygenase-2 gene expression in corneal epithelium. Requirement of calcium in the signal transduction pathway. Invest Ophthalmol. Vis. Sci., 38, 2492-2501.
7. BREMNER, P. & HEINRICH, M. (2002). Natural products as targeted modulators of the nuclear factor-kappaB pathway. J. Pharm. Pharmacol., 54, 453-472.
8. BURGOS, R.A., HIDALGO, M.A., MATTHEI, S.M., HERMOSILLA, R., FOLCH, H. & HANCKE, J.L. (2004). Determination of specific receptor sites for platelet activating factor in bovine neutrophils. Am. J. Vet. Res., 65, 628-636.
9. CAO, W.J., ZHANG, Y.Z., ZHANG, D.H., LI, D.J. & TANG, J.Z. (2004). Inhibition of NF-kappaB by mutant IkappaBalpha enhances TNF-alpha-induced apoptosis in HL-60 cells by controlling bcl-xL expression. Chin. Med. J. (Engl.), 117, 972-977.
10. CASTRILLO, A., DE LAS HERAS, B., HORTELANO, S., RODRIGUEZ, B., VILLAR, A. & BOSCA, L. (2001). Inhibition of the nuclear factor kappa B (NF-kappa B) pathway by tetracyclic kaurene diterpenes in macrophages. Specific effects on NF-kappa B-inducing kinase activity and on the coordinate activation of ERK and p38 MAPK. J. Biol. Chem., 276, 15854-15860.
11. CASTRO-ALCARAZ, S., MISKOLCI, V., KALASAPUDI, B., DAVIDSON, D. & VANCUROVA, I. (2002). NF-kappa B regulation in human neutrophils by nuclear I kappa B alpha: correlation to apoptosis. J. Immunol., 169, 3947-3953.
12. CHAO, W. & OLSON, M.S. (1993). Platelet-activating factor: receptors and signal transduction. Biochem. J., 292 (Part 3), 617-629.
13. CHEN, J.H., HSIAO, G., LEE, A.R., WU, C.C. & YEN, M.H. (2004). Andrographolide suppresses endothelial cell apoptosis via activation of phosphatidyl inositol-3-kinase/Akt pathway. Biochem. Pharmacol., 67, 1337-1345.
14. CHIOU, W.F., CHEN, C.F. & LIN, J.J. (2000). Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide. Br. J. Pharmacol., 129, 1553-1560.
15. CHIOU, W.F., LIN, J.J. & CHEN, C.F. (1998). Andrographolide suppresses the expression of inducible nitric oxide synthase in macrophage and restores the vasoconstriction in rat aorta treated with lipopolysaccharide. Br. J. Pharmacol., 125, 327-334.
16. COON, J.T. & ERNST, E. (2004). Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy. Planta Med., 70, 293-298.
17. GHOSH, S., MAY, M.J. & KOPP, E.B. (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol., 16, 225-260.
18. HABTEMARIAM, S. (1998). Andrographolide inhibits the tumour necrosis factor-alpha-induced upregulation of ICAM-1 expression and endothelial-monocyte adhesion. Phytother. Res., 12, 37-40.
19. HERMOSO, M., BARRERA, N., MORALES, B., PEREZ, S. & VILLALON, M. (2001). Platelet activating factor increases ciliary activity in the hamster oviduct through epithelial production of prostaglandin E2. Pflugers Arch., 442, 336-345.
20. HIDALGO, M.A., OJEDA, F., EYRE, P., LABRANCHE, T.P., SMITH, C., HANCKE, J.L. & BURGOS, R.A. (2004). Platelet-activating factor increases pH(i) in bovine neutrophils through the PI3K-ERK1/2 pathway. Br. J. Pharmacol., 141, 311-321.
21. HILLIARD, B., SAMOILOVA, E.B., LIU, T.S., ROSTAMI, A. & CHEN, Y. (1999). Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice: roles of NF-kappa B in the activation and differentiation of autoreactive T cells. J. Immunol., 163, 2937-2943.
22. IRURETAGOYENA, M.I., TOBAR, J.A., GONZALEZ, P.A., SEPULVEDA, S.E., FIGUEROA, CA., BURGOS, R.A., HANCKE, J.L. & KALERGIS, A.M. (2005). Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse. J. Pharmacol. Exp. Ther., 312 (1).
23. ISHII, S. & SHIMIZU, T. (2000). Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lipid Res., 39, 41-82.
24. JARAMILLO, M. & OLIVIER, M. (2002). Hydrogen peroxide induces murine macrophage chemokine gene transcription via extracellular signal-regulated kinase- and cyclic adenosine 5′-monophosphate (cAMP)-dependent pathways: involvement of NF-kappa B, activator protein 1, and cAMP response element binding protein. J. Immunol., 169, 7026-7038.
25. KARIN, M. & DELHASE, M. (2000). The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin. Immunol., 12, 85-98.
26. KARIN, M., YAMAMOTO, Y. & WANG, Q.M. (2004). The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov., 3, 17-26.
27. KHREISS, T., JOZSEF, L., CHAN, J.S. & FILEP, J.G. (2004). Activation of extracellular signal-regulated kinase couples platelet-activating factor-induced adhesion and delayed apoptosis of human neutrophils. Cell Signal., 16, 801-810.
28. KIM, J.S., KIM, J.M., JUNG, H.C. & SONG, I.S. (2001). Expression of cyclooxygenase-2 in human neutrophils activated by Helicobacter pylori water-soluble proteins: possible involvement of NF-kappaB and MAP kinase signaling pathway. Dig. Dis. Sci., 46, 2277-2284.
29. KUMAR, R.A., SRIDEVI, K., KUMAR, N.V., NANDURI, S. & RAJAGOPAL, S. (2004). Anticancer and immunostimulatory compounds from Andrographis paniculata. J. Ethnopharmacol., 92, 291-295.
30. LEE, J.H., KOO, T.H., HWANG, B.Y. & LEE, J.J. (2002). Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes. J. Biol. Chem., 277, 18411-18420.
31. MARRACHE, A.M., GOBEIL JR, F., BERNIER, S.G., STANKOVA, J., ROLA-PLESZCZYNSKI, M., CHOUFANI, S., BKAILY, G., BOURDEAU, A., SIROIS, M.G., VAZQUEZ-TELLO, A., FAN, L., JOYAL, J.S., FILEP, J.G., VARMA, D.R., RIBEIRO-DA-SILVA, A. & CHEMTOB, S. (2002). Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. J. Immunol., 169, 6474-6481.
32. MCDONALD, P.P., BALD, A. & CASSATELLA, M.A. (1997). Activation of the NF-kappaB pathway by inflammatory stimuli in human neutrophils. Blood, 89, 3421-3433.
33. NICK, J.A., AVDI, N.J., YOUNG, S.K., KNALL, C, GERWINS, P., JOHNSON, G.L. & WORTHEN, G.S. (1997). Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J. Clin. Invest., 99, 975-986.
34. NICK, J.A., AVDI, N.J., YOUNG, S.K., LEHMAN, L.A., MCDONALD, P.P., FRASCH, S.C., BILLSTROM, M.A., HENSON, P.M., JOHNSON, G.L. & WORTHEN, G.S. (1999). Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J. Clin. Invest., 103, 851-858.
35. POULIOT, M., GILBERT, C., BORGEAT, P., POUBELLE, P.E., BOURGOIN, S., CREMINON, C, MACLOUF, J., MCCOLL, S.R. & NACCACHE, P.H. (1998). Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils. FASEB J., 12, 1109-1123.
36. ROEBUCK, K.A. & FINNEGAN, A. (1999). Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J. Leukoc. Biol., 66, 876-888.
37. SANTOS-BENEIT, A.M. & MOLLINEDO, F. (2000). Expression of genes involved in initiation, regulation, and execution of apoptosis in human neutrophils and during neutrophil differentiation of HL-60 cells. J. Leukoc. Biol., 67, 712-724.
38. SATYANARAYANA, C., DEEVI, D.S., RAJAGOPALAN, R., SRINIVAS, N. & RAJAGOPAL, S. (2004). DRF 3188 a novel semi-synthetic analog of andrographolide: cellular response to MCF7 breast cancer cells. BMC Cancer, 4, 26.
39. SHEN, Y.C., CHEN, C.F. & CHIOU, W.F. (2000). Suppression of rat neutrophil reactive oxygen species production and adhesion by the diterpenoid lactone andrographolide. Planta Med., 66, 314-317.
40. SHEN, Y.C., CHEN, C.F. & CHIOU, W.F. (2002). Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. Br. J. Pharmacol., 135, 399-406.
41. SIMEONIDIS, S., STAUEIER, D., CHEN, G., HENDRICKSON, W.A. & THANOS, D. (1999). Mechanisms by which IkappaB proteins control NF-kappaB activity. Proc. Natl. Acad. Sci. U.S.A., 96, 49-54.
42. TAK, P.P. & FIRESTEIN, G.S. (2001). NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest., 107, 7-11.
43. TSAI, H.R., YANG, L.M., TSAI, WJ. & CHIOU, W.F. (2004). Andrographolide acts through inhibition of ERK1/2 and Akt phosphorylation to suppress chemotactic migration. Eur. J. Pharmacol., 498, 45-52.
44. VISEN, P.K., SHUKLA, B., PATNAIK, G.K. & DHAWAN, B.N. (1993). Andrographolide protects rat hepatocytes against paracetamol-induced damage. J. Ethnopharmacol., 40, 131-136.
45. WANG, L.S., CHOW, K.C. & WU, Y.C. (2002). Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells. Scand. J. Gastroenterol., 37, 467-475.
46. WANG, T., LIU, B., ZHANG, W., WILSON, B. & HONG, J.S. (2004). Andrographolide reduces inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuron-glia cultures by inhibiting microglial activation. J. Pharmacol. Exp. Ther., 308, 975-983.
47. WARD, C., CHILVERS, H.R., LAWSON, M.F., PRYDE, J.G., FUJIHARA, S., FARROW, S.N., HASLETT, C. & ROSSI, A.G. (1999). NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro. J. Biol. Chem., 274, 4309-4318.
48. XIA, Y.F., YE, B.Q., LI, Y.D., WANG, J.G., HE, X.J., LIN, X., YAO, X., MA, D., SLUNGAARD, A., HEBBEL, R.P., KEY, N.S. & GENG, J.G. (2004). Andrographolide attenuates inflammation by inhibition of NF-kappaB activation through covalent modification of reduced cysteine 62 of p50. J. Immunol., 173, 4207-4217.